首站-论文投稿智能助手
典型文献
Efficient expansion of rare human circulating hematopoietic stem/progenitor cells in steady-state blood using a polypeptide-forming 3D culture
文献摘要:
Although widely applied in treating hematopoietic malignancies,transplantation of hematopoietic stem/progenitor cells(HSPCs)is impeded by HSPC shortage.Whether circulating HSPCs(cHSPCs)in steady-state blood could be used as an alternative source remains largely elusive.Here we develop a three-dimensional culture system(3DCS)including arginine,glycine,aspartate,and a series of factors.Fourteen-day culture of peripheral blood mononuclear cells(PBMNCs)in 3DCS led to 125-and 70-fold increase of the frequency and number of CD34+cells.Further,3DCS-expanded cHSPCs exhibited the similar reconstitution rate com-pared to CD34+HSPCs in bone marrow.Mechanistically,3DCS fabricated an immunomodulatory niche,secreting cytokines as TNF to support cHSPC survival and proliferation.Finally,3DCS could also promote the expansion of cHSPCs in patients who failed in HSPC mobilization.Our 3DCS successfully expands rare cHSPCs,providing an alternative source for the HSPC therapy,particularly for the patients/donors who have failed in HSPC mobilization.
文献关键词:
作者姓名:
Yulin Xu;Xiangjun Zeng;Mingming Zhang;Binsheng Wang;Xin Guo;Wei Shan;Shuyang Cai;Qian Luo;Honghu Li;Xia Li;Xue Li;Hao Zhang;Limengmeng Wang;Yu Lin;Lizhen Liu;Yanwei Li;Meng Zhang;Xiaohong Yu;Pengxu Qian;He Huang
作者机构:
Bone Marrow Transplantation Center,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310012,China;Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou 311121,China;Institute of Hematology,Zhejiang University,Hangzhou 310012,China;Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy,Hangzhou 310012,China;Core Facilities,Zhejiang University School of Medicine,Hangzhou 310012,China;Dr.Li Dak Sum&Yip Yio Chin Center for Stem Cell and Regenerative Medicine,Zhejiang University,Hangzhou 310012,China
文献出处:
引用格式:
[1]Yulin Xu;Xiangjun Zeng;Mingming Zhang;Binsheng Wang;Xin Guo;Wei Shan;Shuyang Cai;Qian Luo;Honghu Li;Xia Li;Xue Li;Hao Zhang;Limengmeng Wang;Yu Lin;Lizhen Liu;Yanwei Li;Meng Zhang;Xiaohong Yu;Pengxu Qian;He Huang-.Efficient expansion of rare human circulating hematopoietic stem/progenitor cells in steady-state blood using a polypeptide-forming 3D culture)[J].蛋白质与细胞,2022(11):808-824
A类:
cHSPCs,PBMNCs,CD34+cells,CD34+HSPCs,cHSPC
B类:
Efficient,expansion,rare,human,circulating,hematopoietic,progenitor,steady,state,blood,using,polypeptide,forming,culture,Although,widely,applied,treating,malignancies,transplantation,impeded,by,shortage,Whether,could,used,alternative,source,remains,largely,elusive,Here,we,develop,three,dimensional,system,3DCS,including,arginine,glycine,aspartate,series,factors,Fourteen,day,peripheral,mononuclear,fold,increase,frequency,number,Further,expanded,exhibited,similar,reconstitution,rate,com,pared,bone,marrow,Mechanistically,fabricated,immunomodulatory,niche,secreting,cytokines,support,survival,proliferation,Finally,also,promote,patients,who,failed,mobilization,Our,successfully,expands,providing,therapy,particularly,donors,have
AB值:
0.526899
相似文献
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Jia Lu;Ting Li;Zhichao Liao;Hui Yu;Yongtian Zhao;Haixiao Wu;Zhiwu Ren;Jun Zhao;Ruwei Xing;Sheng Teng;Yun Yang;Xiangchun Li;Kexin Chen;Jonathan Trent;Jilong Yang-Department of Bone and Soft Tissue Tumor,2Department of Infection Management,3Key Laboratory of Molecular Cancer Epidemiology,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;YuceBio Technology Co.,Ltd.,Shenzhen 518172,China;Department of Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;Sarcoma Multidisciplinary Program,Sylvester Comprehensive Cancer Center,The University of Miami,Miami,FL 33136,USA
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis
Haoran Mu;Dongqing Zuo;Jie Chen;Zhigang Liu;Zhuo Wang;Liu Yang;Qihui Shi;Yingqi Hua-Shanghai Bone Tumor Institute and Department of Orthopedics,Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200080,China;Key Laboratory of Systems Biomedicine(Ministry of Education),Shanghai Center for Systems Biomedicine,Shanghai Jiao Tong University,Shanghai 200240,China;Shanghai Key Laboratory of Medical Epigenetics and the International Co-laboratory of Medical Epigenetics and Metabolism(MOST),Institutes of Biomedical Sciences,Fudan University,Shanghai 200032,China;Key Laboratory of Whole-Period Monitoring and Precise Intervention of Digestive Cancer(SMHC)and Institute of Fudan-Minhang Academic Health System,Minhang Hospital,Fudan University,Shanghai 201199,China;Shanghai Engineering Research Center of Biomedical Analysis Reagents,Shanghai 201203,China
Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury
Ting-Ting Cao;Huan Chen;Mao Pang;Si-Si Xu;Hui-Quan Wen;Bin Liu;Li-Min Rong;Mang-Mang Li-Department of Cell Biology,School of Basic Medical Sciences,Southern Medical University,Guangzhou,Guangdong Province,China;Department of Spine Surgery,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong Province,China;Guangdong Provincial Center for Engineering and Technology Research of Minimally Invasive Spine Surgery,Guangzhou,Guangdong Province,China;Guangdong Provincial Center for Quality Control of Minimally Invasive Spine Surgery,Guangzhou,Guangdong Province,China;Department of Radiology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong Province,China
A broadly neutralizing human monoclonal antibody against the hemagglutinin of avian influenza virus H7N9
Li Jingxin;Zhang Li;Bao Linlin;Wang Yuxiao;Qiu Lin;Hu Jialei;Tang Rong;Yu Huiyan;Shan Jun;Li Yan;Qin Chuan;Zhu Fengcai-Department for Vaccine Clinical Evaluation, NHC Key Laboratory of Enteric Pathogenic Microbiology, Jlangsu Provincial Center for Diseases Control and Prevention, Nanjing, Jiangsu 210009, China;Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Center, Peking Union Medical Collage (PUMC); Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, Beijing 100101, China;Department of Public Health, Southeast University, Nanjing, Jiangsu 210009, China;Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission
Zhang Yongzhan;Bai Lu;Cheng Yifei;Lu Aidong;Wang Yu;Wu Jun;Zhang Xiaohui;Zuo Yingxi;Xu Lanping;Jia Yueping;Huang Xiaojun;Zhang Leping-Department of Pediatrics, Peking University People’s Hospital, Peking University, Beijing 100044, China;Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China;Department of Pediatrics, Peking University Shougang Hospital, Peking University, Beijing 100144, China;Department of Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China
A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
Zheng Xiang;Zhang Weijie;Zhou Hua;Cao Ronghua;Shou Zhangfei;Zhang Shuwei;Cheng Ying;Chen Xuchun;Ding Chenguang;Tang Zuofu;Li Ning;Shi Shaohua;Zhou Qiang;Chen Qiuyuan;Chen Gang;Chen Zheng;Zhou Peijun;Hu Xiaopeng;Zhang Xiaodong;Na Ning;Wang Wei-Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China;Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430032, China;Kidney Transplantation Dialysis Center, The Second People’s Hospital of Shanxi Province, Taiyuan, Shanxi 030012, China;Department of Organ Transplantation, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510120, China;Department of Nephrology, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310000, China;Department of Urology, Ningbo Yinzhou Number. 2 Hospital, Ningbo, Zhejiang 315000, China;Department of Organ Transplantation, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China;Institute of Kidney Transplantation, The First Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China;Department of Kidney, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China;Department of Kidney, Southwest Hospital, The First Hospital Affiliated to The Third Military Medical University (Army Medical University), Chongqing 400000, China;Organ Transplant Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China;Kidney Transplantation Center, Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200000, China
Identification of HSC/MPP expansion units in fetal liver by single-cell spatiotemporal transcriptomics
Suwei Gao;Qiang Shi;Yifan Zhang;Guixian Liang;Zhixin Kang;Baofeng Huang;Dongyuan Ma;Lu Wang;Jianwei Jiao;Xiangdong Fang;Cheng-Ran Xu;Longqi Liu;Xun Xu;Berthold G(o)ttgens;Cheng Li;Feng Liu-State Key Laboratory of Membrane Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing,China;Institute for Stem Cell and Regeneration,Chinese Academy of Sciences,Beijing,China;University of Chinese Academy of Sciences,Beijing,China;School of Life Sciences,Center for Bioinformatics,Center for Statistical Science,Peking University,Beijing,China;State Key Laboratory of Experimental Hematology,Institute of Hematology and Blood Diseases Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Tianjin,China;State Key Laboratory of Stem Cell and Reproductive Biology,Institute of Zoology,Chinese Academy of Sciences,Beijing,China;CAS Key Laboratory of Genome Science & Information,Beijing Institute of Genomics,Chinese Academy of Sciences/China National Center for Bioinformation,Beijing,China;Beijing Key Laboratory of Genome and Precision Medicine Technologies,Beijing,China;Department of Human Anatomy,Histology,and Embryology,School of Basic Medical Sciences,Peking University,Beijing,China;Peking-Tsinghua Center for Life Sciences,Peking University,Beijing,China;BGI-ShenZhen,Shenzhen,Guangdong,China;Shenzhen Bay Laboratory,Shenzhen,Guangdong,China;Guangdong Provincial Key Laboratory of Genome Read and Write,Shenzhen,Guangdong,China;Department of Haematology,Wellcome-Medical Research Council Cambridge Stem Cell Institute,University of Cambridge,Cambridge,UK
Depression compromises antiviral innate immunity via the AVP-AHI1-Tyk2 axis
Hong-Guang Zhang;Bin Wang;Yong Yang;Xuan Liu;Junjie Wang;Ning Xin;Shifeng Li;Ying Miao;Qiuyu Wu;Tingting Guo;Yukang Yuan;Yibo Zuo;Xiangjie Chen;Tengfei Ren;Chunsheng Dong;Jun Wang;Hang Ruan;Miao Sun;Xingshun Xu;Hui Zheng-International Institute of Infection and Immunity,Institutes of Biology and Medical Sciences,Soochow University,Suzhou,Jiangsu,China;Jiangsu Key Laboratory of Infection and Immunity,Soochow University,Suzhou,Jiangsu,China;Institute of Neuroscience,Soochow University,Suzhou,Jiangsu,China;Institute for Fetology,the First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China;Department of Psychiatry,the Affiliated Guangji Hospital of Soochow University,Suzhou,Jiangsu,China;Department of Neurology,the First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China;Department of Intensive Care Medicine,the First Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China;Jiangsu Key Laboratory of Neuropsychiatric Diseases,Soochow University,Suzhou,Jiangsu,China
Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies:a phase I clinical study
Yongxian Hu;Yali Zhou;Mingming Zhang;Houli Zhao;Guoqing Wei;Wengang Ge;Qu Cui;Qitian Mu;Gong Chen;Lu Han;Tingting Guo;Jiazhen Cui;Xiaoyan Jiang;Xiujun Zheng;Shuhui Yu;Xiaolong Li;Xingwang Zhang;Mingxi Chen;Xiuju Li;Ming Gao;Kang Wang;Cheng Zu;Hao Zhang;Xiaohong He;Yanbin Wang;Dongrui Wang;Jiangtao Ren;He Huang-Bone Marrow Transplantation Center,The First Affiliated Hospital,School of Medicine,Zhejiang University,Hangzhou,Zhejiang,China;Liangzhu Laboratory,Zhejiang University Medical Center,Hangzhou,Zhejiang,China;Institute of Hematology,Zhejiang University,Hangzhou,Zhejiang,China;Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy,Hangzhou,Zhejiang,China;Nanjing Bioheng Biotech Co.,Ltd,Nanjing,Jiangsu,China;Department of Hematology,Ruian people's Hospital,Wenzhou,Zhejiang,China;Department of Hematology,Beijing Tiantan Hospital,Capital Medical University Beijing China;Laboratory of Stem Cell Transplantation Ningbo First Hospital Ningbo,Zhejiang,China
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis
Jiansong Huang;Xin Huang;Yang Li;Xia Li;Jinghan Wang;Fenglin Li;Xiao Yan;Huanping Wang;Yungui Wang;Xiangjie Lin;Jifang Tu;Daqiang He;Wenle Ye;Min Yang;Jie Jin-Department of Hematology,Key Laboratory of Hematologic Malignancies,Diagnosis and Treatment,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Institute of Hematology,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Obstetrics,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Hematology,Qingdao Municipal Hospital,Qingdao 266000,China;Department of Laboratory Medicine,Affiliated Hangzhou First People's Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Cancer Center Zhejiang University,Hangzhou 310058,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。